1673 participants
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-04
- Start Date:
- 2011-06-17
- Completion:
- 2019-02-15
Conditions
- Melanoma of Unknown Primary
- Recurrent Melanoma
- Stage IIIB Cutaneous Melanoma AJCC v7
- Stage IIIC Cutaneous Melanoma AJCC v7
- Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
- BIOLOGICAL
- OTHER